While the association between Covid vaccination and myocarditis is well established, a recent case study documented how inflammatory dilated cardiomyopathy (another heart inflammation disorder) was induced by the Pfizer (BNT162b2) injection.
“A 78-year-old previously healthy female was referred by her family physician and admitted to our hospital for management of dyspnoea 11 days after receiving the third mRNA-1273 vaccine dose. The patient underwent a primary two-dose BNT162b2 series. On the fourth day after vaccination, the patient experienced palpitations and dyspnoea, which gradually worsened,” the case study said in the ‘Case Report’ section. “Therefore, the temporal relationship between the preceding COVID-19 immunization and the occurrence of iDCM with no other identifiable cause led to the final diagnosis of COVID-19 VAM.”
Thankfully for the patient, her condition improved with oral prednisolone treatment, which was documented via chest X-ray (CXR) and electrocardiography (ECG). One may note the reduction in size of the inflamed heart post-treatment.
Hellbound and Down 